Search

You searched for "regenerative"

1551 results found
Ophthalmologica journal cover image

Evaluation of Optive® in ocular discomfort after anti-VEGF intravitreal injection

1 October 2021 | | EYE - Vitreo-Retinal | Artificial tear, Intravitreal injection therapy, Ocular discomfort, Ocular surface
In this study the authors prospectively evaluated the efficacy of Optive® eye drops after in full, then abbreviation - intravitreal injection (IVT). Patients naïve to IVT were included in the study. No artificial tear treatment was prescribed after the first...
The Lancet Global Health cover image.

The potential of artificial intelligence and digital health in global eye health

3 April 2024 | | EYE - Vitreo-Retinal
This article provides an overview of the current landscape of artificial intelligence (AI) and digital health in global eye health. Tan, et al. note that though significant progress has been made in global eye health over the last few decades,...
Ophthalmologica journal cover image.

EDOF intraocular lens in eyes with preexisting retinal disease

30 May 2025 | | EYE - Vitreo-Retinal
Extended depth of focus (EDOF) intraocular lens (IOL) offers improved near and intermediate vision, aiming to reduce spectacle dependence in cataract patients. This study aims to evaluate the performance of EDOF lenses following cataract surgery in patients with retinal pathology....

Mainline Instruments Announces NHS Approval for iCare DRSplus Fundus Imaging System

23 April 2025 | Company Profiles, Research & Development, Contracts & Distributors
Mainline Instruments is excited to share that the iCare DRSPlus Confocal Fundus Imaging System has received official approval from the NHS for use in the Diabetic Eye Screening (DES) Programme. This recognition follows a rigorous evaluation process, confirming that the...

MacuMira and Keeler announce strategic partnership to expand dry AMD therapy

11 December 2025 | Contracts & Distributors, Research & Development
Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...

Everyday diabetes medicine could treat common cause of blindness

16 February 2026 | research, pharma
Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...

Bus drivers swap with blind passengers

18 May 2026 | patient stories
Drivers at the Xplore Dundee depot took part in a hands-on session today [Wednesday 6 May] to better understand the experiences of blind and partially sighted passengers. The company held a ‘Swap With Me’ event in which volunteers from national...

Belfast Eye Conference 2024

22 June 2024 -23 June 2024
by Zina Mobarak, FY1 Doctor, Manchester University Foundation Trust, UK. The Belfast Eye conference was held online over two days, aimed at anyone interested in ophthalmology and focused on delivering informative talks from specialists in various ophthalmic specialties and presenting...

Management of a giant pigment epithelium detachment with transition from half- to full-dose aflibercept

2 March 2026 | | EYE - Imaging, EYE - Vitreo-Retinal
This case report describes the management of a giant pigment epithelial detachment (PED) in neovascular age-related macular degeneration (nAMD) using half-dose aflibercept. An 80-year-old woman presented with a huge PED (maximum height 1338µm) and multiple risk factors for retinal pigment...

General purpose AI: Transitioning from high performance in highly curated settings to useful applications in ophthalmology

2 August 2024 | | EYE - General
Artificial intelligence (AI) may be understood as the ability of machines to perform tasks which otherwise require human perception, reasoning, or learning. With the advent of deep learning, AI has achieved remarkable results across a wide range of medical tasks...

In conversation with Marc Labetoulle

9 December 2024 | | EYE - Cornea
Following the hugely successful 10th Tear Film & Ocular Surface Society (TFOS) 2024 Conference which took place in Venice, Italy between 30 October – 2 November, we managed to have a quick Q&A with presenting attendee, Marc Labetoulle. Delivering his...

Specialist registration via the portfolio pathway

26 November 2026
This is a one day workshop for doctors who wish to obtain specialist registration via the Portfolio Pathway. The programme will include an overview of the Portfolio pathway process, guidance on what evidence to submit, tips from those who have...